Sterol biosynthesis pathway as target for anti-trypanosomatid drugs
Autor(a) principal: | |
---|---|
Data de Publicação: | 2009 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional do INMETRO |
Texto Completo: | http://hdl.handle.net/10926/1299 |
Resumo: | Sterols are constituents of the cellular membranes that are essential for their normal structure and function. In mammalian cells, cholesterol is the main sterol found in the various membranes. However, other sterols predominate in eukaryotic microorganisms such as fungi and protozoa. It is now well established that an important metabolic pathway in fungi and in members of the Trypanosomatidae family is one that produces a special class of sterols, including ergosterol, and other 24-methyl sterols, which are required for parasitic growth and viability, but are absent from mammalian host cells. Currently, there are several drugs that interfere with sterol biosynthesis (SB) that are in use to treat diseases such as high cholesterol in humans and fungal infections. In this review, we analyze the effects of drugs such as (a) statins, which act on the mevalonate pathway by inhibiting HMGCoA reductase, (b) bisphosphonates, which interfere with the isoprenoid pathway in the step catalyzed by farnesyl diphosphate synthase, (c) zaragozic acids and quinuclidines, inhibitors of squalene synthase (SQS), which catalyzes the first committed step in sterol biosynthesis, (d) allylamines, inhibitors of squalene epoxidase, (e) azoles, which inhibit C14α-demethylase, and (f) azasterols, which inhibit Δ24(25)-sterol methyltransferase (SMT). Inhibition of this last step appears to have high selectivity for fungi and trypanosomatids, since this enzyme is not found in mammalian cells. We review here the IC50 values of these various inhibitors, their effects on the growth of trypanosomatids (both in axenic cultures and in cell cultures), and their effects on protozoan structural organization (as evaluted by light and electron microscopy) and lipid composition. The results show that the mitochondrial membrane as well as the membrane lining the protozoan cell body and flagellum are the main targets. Probably as a consequence of these primary effects, other important changes take place in the organization of the kinetoplast DNA network and on the protozoan cell cycle. In addition, apoptosis-like and autophagic processes induced by several of the inhibitors tested led to parasite death. |
id |
INMT_5f9bb2add42d01060126f9677a310854 |
---|---|
oai_identifier_str |
oai:xrepo01s.inmetro.gov.br:10926/1299 |
network_acronym_str |
INMT |
network_name_str |
Repositório Institucional do INMETRO |
repository_id_str |
|
spelling |
info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleSterol biosynthesis pathway as target for anti-trypanosomatid drugs20092011-12-13T20:12:21Z2011-12-13T20:12:21ZSterols are constituents of the cellular membranes that are essential for their normal structure and function. In mammalian cells, cholesterol is the main sterol found in the various membranes. However, other sterols predominate in eukaryotic microorganisms such as fungi and protozoa. It is now well established that an important metabolic pathway in fungi and in members of the Trypanosomatidae family is one that produces a special class of sterols, including ergosterol, and other 24-methyl sterols, which are required for parasitic growth and viability, but are absent from mammalian host cells. Currently, there are several drugs that interfere with sterol biosynthesis (SB) that are in use to treat diseases such as high cholesterol in humans and fungal infections. In this review, we analyze the effects of drugs such as (a) statins, which act on the mevalonate pathway by inhibiting HMGCoA reductase, (b) bisphosphonates, which interfere with the isoprenoid pathway in the step catalyzed by farnesyl diphosphate synthase, (c) zaragozic acids and quinuclidines, inhibitors of squalene synthase (SQS), which catalyzes the first committed step in sterol biosynthesis, (d) allylamines, inhibitors of squalene epoxidase, (e) azoles, which inhibit C14α-demethylase, and (f) azasterols, which inhibit Δ24(25)-sterol methyltransferase (SMT). Inhibition of this last step appears to have high selectivity for fungi and trypanosomatids, since this enzyme is not found in mammalian cells. We review here the IC50 values of these various inhibitors, their effects on the growth of trypanosomatids (both in axenic cultures and in cell cultures), and their effects on protozoan structural organization (as evaluted by light and electron microscopy) and lipid composition. The results show that the mitochondrial membrane as well as the membrane lining the protozoan cell body and flagellum are the main targets. Probably as a consequence of these primary effects, other important changes take place in the organization of the kinetoplast DNA network and on the protozoan cell cycle. In addition, apoptosis-like and autophagic processes induced by several of the inhibitors tested led to parasite death.19 p. : il.Submitted by Cintia Machado (cpmachado@yahoo.com.br) on 2011-08-22T16:59:20Z No. of bitstreams: 1 2009_SouzaRodrigues.pdf: 20922227 bytes, checksum: 4361164d98858b27f7227d2a2e820c2d (MD5)Approved for entry into archive by Catarina Soares(cfsoares@inmetro.gov.br) on 2011-12-13T20:12:21Z (GMT) No. of bitstreams: 1 2009_SouzaRodrigues.pdf: 20922227 bytes, checksum: 4361164d98858b27f7227d2a2e820c2d (MD5)Made available in DSpace on 2011-12-13T20:12:21Z (GMT). No. of bitstreams: 1 2009_SouzaRodrigues.pdf: 20922227 bytes, checksum: 4361164d98858b27f7227d2a2e820c2d (MD5) Previous issue date: 2009enghttp://hdl.handle.net/10926/1299DMD_hdl_10926/1299SOUZA, Wanderley de; RODRIGUES, Juliany Cola Fernandes. Sterol biosynthesis pathway as target for anti-trypanosomatid drugs. Interdisciplinary Perspectives on Infectious Diseases, v. 2009, p. 1-19, 2009.Souza, Wanderley deRodrigues, Juliany Cola Fernandesinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional do INMETROinstname:Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO)instacron:INMETROSouza_2009.pdfhttp://xrepo01s.inmetro.gov.br/bitstream/10926/1299/1/Souza_2009.pdfapplication/pdf20922227http://xrepo01s.inmetro.gov.br/bitstream/10926/1299/1/Souza_2009.pdf4361164d98858b27f7227d2a2e820c2dMD510926_1299_1Souza_2009.pdf.txthttp://xrepo01s.inmetro.gov.br/bitstream/10926/1299/6/Souza_2009.pdf.txttext/plain80724http://xrepo01s.inmetro.gov.br/bitstream/10926/1299/6/Souza_2009.pdf.txt1709fb9f447ed78b0f94564a94265feeMD510926_1299_62025-02-07T14:19:37Zoai:xrepo01s.inmetro.gov.br:10926/1299Repositório de Publicaçõeshttp://repositorios.inmetro.gov.br/oai/requestopendoar:2013-10-02T14:00:56Repositório Institucional do INMETRO - Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO)false |
dc.title.none.fl_str_mv |
Sterol biosynthesis pathway as target for anti-trypanosomatid drugs |
title |
Sterol biosynthesis pathway as target for anti-trypanosomatid drugs |
spellingShingle |
Sterol biosynthesis pathway as target for anti-trypanosomatid drugs Souza, Wanderley de |
title_short |
Sterol biosynthesis pathway as target for anti-trypanosomatid drugs |
title_full |
Sterol biosynthesis pathway as target for anti-trypanosomatid drugs |
title_fullStr |
Sterol biosynthesis pathway as target for anti-trypanosomatid drugs |
title_full_unstemmed |
Sterol biosynthesis pathway as target for anti-trypanosomatid drugs |
title_sort |
Sterol biosynthesis pathway as target for anti-trypanosomatid drugs |
author |
Souza, Wanderley de |
author_facet |
Souza, Wanderley de Rodrigues, Juliany Cola Fernandes |
author_role |
author |
author2 |
Rodrigues, Juliany Cola Fernandes |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Souza, Wanderley de Rodrigues, Juliany Cola Fernandes |
description |
Sterols are constituents of the cellular membranes that are essential for their normal structure and function. In mammalian cells, cholesterol is the main sterol found in the various membranes. However, other sterols predominate in eukaryotic microorganisms such as fungi and protozoa. It is now well established that an important metabolic pathway in fungi and in members of the Trypanosomatidae family is one that produces a special class of sterols, including ergosterol, and other 24-methyl sterols, which are required for parasitic growth and viability, but are absent from mammalian host cells. Currently, there are several drugs that interfere with sterol biosynthesis (SB) that are in use to treat diseases such as high cholesterol in humans and fungal infections. In this review, we analyze the effects of drugs such as (a) statins, which act on the mevalonate pathway by inhibiting HMGCoA reductase, (b) bisphosphonates, which interfere with the isoprenoid pathway in the step catalyzed by farnesyl diphosphate synthase, (c) zaragozic acids and quinuclidines, inhibitors of squalene synthase (SQS), which catalyzes the first committed step in sterol biosynthesis, (d) allylamines, inhibitors of squalene epoxidase, (e) azoles, which inhibit C14α-demethylase, and (f) azasterols, which inhibit Δ24(25)-sterol methyltransferase (SMT). Inhibition of this last step appears to have high selectivity for fungi and trypanosomatids, since this enzyme is not found in mammalian cells. We review here the IC50 values of these various inhibitors, their effects on the growth of trypanosomatids (both in axenic cultures and in cell cultures), and their effects on protozoan structural organization (as evaluted by light and electron microscopy) and lipid composition. The results show that the mitochondrial membrane as well as the membrane lining the protozoan cell body and flagellum are the main targets. Probably as a consequence of these primary effects, other important changes take place in the organization of the kinetoplast DNA network and on the protozoan cell cycle. In addition, apoptosis-like and autophagic processes induced by several of the inhibitors tested led to parasite death. |
publishDate |
2009 |
dc.date.issued.fl_str_mv |
2009 |
dc.date.available.fl_str_mv |
2011-12-13T20:12:21Z |
dc.date.accessioned.fl_str_mv |
2011-12-13T20:12:21Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10926/1299 DMD_hdl_10926/1299 |
dc.identifier.citation.fl_str_mv |
SOUZA, Wanderley de; RODRIGUES, Juliany Cola Fernandes. Sterol biosynthesis pathway as target for anti-trypanosomatid drugs. Interdisciplinary Perspectives on Infectious Diseases, v. 2009, p. 1-19, 2009. |
url |
http://hdl.handle.net/10926/1299 |
identifier_str_mv |
DMD_hdl_10926/1299 SOUZA, Wanderley de; RODRIGUES, Juliany Cola Fernandes. Sterol biosynthesis pathway as target for anti-trypanosomatid drugs. Interdisciplinary Perspectives on Infectious Diseases, v. 2009, p. 1-19, 2009. |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.bitstream.fl_str_mv |
application/pdf text/plain |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional do INMETRO instname:Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO) instacron:INMETRO |
instname_str |
Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO) |
instacron_str |
INMETRO |
institution |
INMETRO |
reponame_str |
Repositório Institucional do INMETRO |
collection |
Repositório Institucional do INMETRO |
repository.name.fl_str_mv |
Repositório Institucional do INMETRO - Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO) |
repository.mail.fl_str_mv |
|
_version_ |
1823420209155801088 |